United States: FDA Releases Action Plan For Artificial Intelligence/Machine Learning-Enabled Software As A Medical Device - Akin Gump Strauss Hauer & Feld LLP
After much anticipation, on January 12, 2021, the U.S. Food and Drug Administration (FDA) released its first "Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device...
Full Article